Search
Displaying 731–740 of 1084 results
-
Rachel Wants to Raise White Cane Awareness
Beacon StoriesRachel Luehrs describes her journey of acceptance.
-
Raising Our Sights DIY Fundraising FAQ
An FAQ about the opportunities for the Raising Our Sights DIY fundraising program for the Foundation Fighting Blindness.
-
The Bergstein’s Are Striking Out Blindness
Fundraiser Success StoriesThe Bergstein family has always been passionate about helping the Foundation Fighting Blindness.
-
FDA Approves New Wet AMD Treatment that can be Administered Every Three Months
Research NewsBeovu from Novartis reduces treatment burden for wet AMD patients
-
VISIONS 2018 Session Audio Recordings
Great content from the VISIONS 2018 conference held in San Diego, California!
-
The Foundation Fighting Blindness is a beacon for those affected by blinding retinal diseases. Our public service announcement campaign focuses on empowerment and showcases the idea that no matter an individual’s diagnosis, it’s their drive that fuels them to pursue their passion and interests. Collectively, we are stronger together – as a community.
-
Foundation News
The program will offer patients with inherited retinal disease no-cost genetic testing and genetic counseling in the United States. Look for updated information on how to participate to be posted in mid-October, with program registration starting shortly thereafter.
-
AGTC Reports Promising Interim Results for XLRP and Achromatopsia Gene Therapy Trials
Research NewsAGTC used Foundation’s My Retina Tracker registry to recruit patients for trials
-
The Show Must Go on Despite Vision Loss Due to Stargardts
Beacon StoriesEmmy Award-Winning Writer and Performer Ellen Gould Weaves her Personal Experience with Stargardts Into Her New Musical, “Seeing Stars”
-
Consortium Genetically Tests 40 Percent of People in Israel with IRDs
Research NewsPatient benefits from genetic testing for IRDs include confirmation of their clinical diagnosis, identification of the disease inheritance pattern and risk for other family members, and determination of human studies for emerging therapies that may be appropriate for them.
.png)
